Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2016-12-19 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于不设副董事长和更选总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement from the company about changes in its board and senior management positions, specifically about not setting a vice chairman and appointing a new general manager. It includes details about the board meeting and resolutions passed. There is no financial data, no mention of financial results, no audit information, and no regulatory filings or voting results. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming the classification.
2016-12-19 Chinese
第一届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 16th meeting of the first board of directors of the company. It details decisions about amendments to the company charter, changes in board and management positions, use of idle raised funds, and scheduling of a shareholders meeting. The content focuses on board meeting decisions and management changes rather than financial results or reports. It is not a full annual or interim report, nor an earnings release or audit report. The document is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 2237 characters, which is consistent with a meeting resolution announcement rather than a full report.
2016-12-19 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a listed company (stock code 002826) regarding abnormal stock price fluctuations over a specific period (December 14-16, 2016). It explains the situation, confirms no undisclosed material information, and provides detailed risk disclosures related to the company's business and market environment. The document does not contain financial statements or quarterly/yearly financial results but focuses on stock trading behavior and risk factors. It is not an earnings release, annual report, or interim report. It is a regulatory announcement related to stock price abnormality and risk disclosure, typical of a Regulatory Filing (RNS). The document length (6418 characters) and content support this classification rather than a full financial report or other specific filings.
2016-12-18 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by a company listed on the Shenzhen Stock Exchange. It discusses the stock price movement over two trading days, confirms no undisclosed material information, and provides detailed risk factors related to the company's business and operations. It references regulatory rules from the Shenzhen Stock Exchange and includes a risk warning to investors. The document does not contain financial statements or detailed financial results but is a regulatory disclosure about stock price abnormality and related risk factors. This fits the category of a Regulatory Filing (RNS) as it is a compliance announcement related to stock trading rules and risk disclosures, not a financial report or earnings release.
2016-12-13 Chinese
关于签署募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a company's initial public offering (IPO). It details the amount of funds raised, the opening of special accounts for the funds, the responsibilities of the involved parties, and the supervisory mechanisms. The document does not contain financial statements or detailed financial performance data but rather focuses on the management and supervision of the raised capital. It is a regulatory announcement about financing activities and capital management rather than a full financial report or audit. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2176 characters, which is relatively short and consistent with an announcement rather than a full report.
2016-12-12 Chinese
上市首日风险提示公告
Regulatory Filings Classification · 95% confidence The document is a risk warning announcement related to the company's first day of stock listing on the Shenzhen Stock Exchange. It includes audited financial data for multiple years and interim periods, mentions the audit firm and audit reports, and discusses business risks and operational details. The document is not a full annual or interim report but rather a detailed announcement accompanying the IPO listing, including financial highlights and risk disclosures. It is not a simple notice of report publication or certification. Given the detailed financial data and risk analysis, but the context being a listing risk warning announcement, this fits best under Regulatory Filings (RNS) as it is a regulatory announcement related to listing and risk disclosure rather than a formal annual or interim report or earnings release.
2016-12-08 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.